MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-14.99%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$290M
AUM Growth
+$290M
(-17%)
Cap. Flow
-$8.48M
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Exelixis
EXEL
|
$8.15M |
| 2 |
Alkermes
ALKS
|
$325K |
Sector Composition
| 1 | Healthcare | 96.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $200M | 68.93% | 14,413,873 -587,200 | -4% | -$8.15M |
|
2
Esperion Therapeutics
ESPR
$448M
| $68.1M | 23.47% | 2,679,835 | – | – |
|
|
3
Alkermes
ALKS
$4.78B
| $10.1M | 3.46% | 864,417 -27,983 | -3% | -$325K |
|
4
iShares MSCI India ETF
INDA
$9.17B
| $6.22M | 2.14% | 320,000 | – | – |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $5.23M | 1.8% | 400,000 | – | – |
|
6
Celldex Therapeutics
CLDX
$1.47B
| $563K | 0.19% | 420,846 | – | – |
|